亚洲分子靶向治疗发展展望
—— 作者: 时间:2008-08-01
阅读数:
1317
简介:The success of sorafenib has spurred investigations into exploration of MTTs for HCC.The high incidence, as well as the geographic difference in clinical practice and etiology of HCC, mandate translational research works of MTTs in Asia.
请登录后查看详细内容
标签:
中文幻灯
精彩幻灯
其他肝病
发表评论
全部评论